Related Experiment Video
Updated: Jan 28, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
Multiple keratin granulomata: A potential histologic clue to cutaneous squamous cell carcinoma responding to
Benjamin J Kahn1, Douglas Parker1, Melinda Yushak2
1Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
Abstract:
We present histologic features of a locally advanced cutaneous squamous cell carcinoma (cSCC) treated with the programmed cell death protein-1 (PD-1) antagonist, pembrolizumab, with a partial response. This contributes to a growing body of literature supporting the efficacy of pembrolizumab in treatment of surgically unresectable cSCC. We also provide a detailed description of the histologic features, particularly keratin granulomata with adjacent lymphocytic aggregates and fibrosis, observed in cSCC under treatment with a PD-1 antagonist.
Insights
Pembrolizumab shows efficacy in treating advanced cutaneous squamous cell carcinoma (cSCC). Histologic examination reveals specific features like keratin granulomata in cSCC responding to PD-1 antagonist therapy.
Area of Science:
- Oncology
- Dermatology
- Immunohistochemistry
Background:
- Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer.
- Surgically unresectable cSCC poses treatment challenges.
- Programmed cell death protein-1 (PD-1) antagonists offer a therapeutic option.
Observation:
- Histologic features of cSCC treated with pembrolizumab were analyzed.
- Partial response was observed in a patient with locally advanced cSCC.
- Specific microscopic changes were noted during PD-1 antagonist treatment.
Findings:
- Pembrolizumab demonstrated efficacy in a case of locally advanced cSCC.
- Key histologic findings included keratin granulomata with lymphocytic aggregates and fibrosis.
- These features are associated with response to PD-1 blockade in cSCC.
Implications:
- This case supports pembrolizumab's role in managing unresectable cSCC.
- Understanding treatment-related histologic changes aids in evaluating therapeutic response.
- Further research into PD-1 inhibitor mechanisms in cSCC is warranted.
Related Concept Videos
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Gene Therapy

